Implications of mutational spectrum in myelodysplastic syndromes based on targeted next-generation sequencing.

about

Implications of mutational spectrum in myelodysplastic syndromes based on targeted next-generation sequencing.

Item

http://www.wikidata.org/entity/Q47130430

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Implications of mutational spe ...... ed next-generation sequencing.

@en

Implications of mutational spe ...... ed next-generation sequencing.

@nl

type

Item

label

Implications of mutational spe ...... ed next-generation sequencing.

@en

Implications of mutational spe ...... ed next-generation sequencing.

@nl

prefLabel

Implications of mutational spe ...... ed next-generation sequencing.

@en

Implications of mutational spe ...... ed next-generation sequencing.

@nl

P1476

Implications of mutational spe ...... ed next-generation sequencing.

@en

P2093

Chongjian Chen

http://www.w3.org/2001/XMLSchema#string

Guangyuan Hou

http://www.w3.org/2001/XMLSchema#string

Jian Bo

http://www.w3.org/2001/XMLSchema#string

Jing Guo

http://www.w3.org/2001/XMLSchema#string

Li Yu

http://www.w3.org/2001/XMLSchema#string

Lili Wang

http://www.w3.org/2001/XMLSchema#string

Liping Dou

http://www.w3.org/2001/XMLSchema#string

Na Lv

http://www.w3.org/2001/XMLSchema#string

Qingyu Xu

http://www.w3.org/2001/XMLSchema#string

Xiuli Wang

http://www.w3.org/2001/XMLSchema#string

P2860

The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes

Targeting epigenetic pathways in acute myeloid leukemia and myelodysplastic syndrome: a systematic review of hypomethylating agents trials

The JAK2V617F activating mutation occurs in chronic myelomonocytic leukemia and acute myeloid leukemia, but not in acute lymphoblastic leukemia or chronic lymphocytic leukemia

Somatic mutations of the histone methyltransferase gene EZH2 in myelodysplastic syndromes.

Recurrent DNMT3A mutations in patients with myelodysplastic syndromes

Somatic SF3B1 mutation in myelodysplasia with ring sideroblasts

DNMT3A R882 mutations in patients with cytogenetically normal acute myeloid leukemia and myelodysplastic syndrome.

The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia.

Genomic Classification and Prognosis in Acute Myeloid Leukemia.

International scoring system for evaluating prognosis in myelodysplastic syndromes

P304

82475-82490

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.18632/ONCOTARGET.19628

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-07-27T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29137279

http://www.w3.org/2001/XMLSchema#string

P932

5669905

http://www.w3.org/2001/XMLSchema#string